BOSTON ( Reuters ) - Schering-Plough Corp ( SGP.N : Quote , Profile , Research ) said on Thursday that it expects to report higher sales of its cholesterol drugs Vytorin and Zetia in the fourth quarter of 2007 and in 2008 even though they face growing competition .